-5 -associated with GR and JNK1. In PBMCs from severe asthmatics, DUSP4 expression was reduced versus healthy subjects and negatively correlated with phosphorylation levels of GR-Ser 226 and JNK1. Formoterol enhanced DUSP4 activity and restored corticosteroid sensitivity reduced by DUSP4 siRNA. In conclusion, DUSP4 regulates corticosteroid sensitivity via dephosphorylation of JNK1 and GR-Ser 226 . DUSP4 activation by formoterol restores impaired corticosteroid sensitivity, indicating that DUSP4 is crucial in regulating corticosteroid sensitivity and therefore might be a novel therapeutic target in severe asthma.
Introduction
Most patients with bronchial asthma, one of major inflammatory airway diseases, are now well controlled by inhaled corticosteroids (Barnes, 2010) . However, some severe asthmatics have uncontrolled disease despite treatment with high doses of inhaled corticosteroids. A major unmet need is the development of more effective treatment for these patients with corticosteroid-insensitive asthma.
The c-Jun N-terminal kinases (JNKs), members of stress-activated protein kinases, are activated by many environmental stimuli such as proinflammatory cytokines, radiation, osmotic stress, and oxidative stress (Shen and Liu, 2006) . Previously, Sousa et al. reported that JNK was hyperphosphorylated in peripheral blood mononuclear cells (PBMCs) from patients with corticosteroid-insensitive asthma (Sousa et al., 1999) . We also confirmed that phosphorylation levels of JNK1 are enhanced in PBMCs from patients with severe asthma and with IL-2/IL-4-induced steroid-insensitivity in PBMCs (Kobayashi et al., 2011) . Thus, JNK1 phosphorylation is a key factor of corticosteroid insensitivity, at least in severe asthma.
Multiple factors can be involved in corticosteroid insensitivity in severe asthma; such as decreased glucocorticoid receptor (GR) expression, defective GR-ligand binding, reduced 
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-7 -GR nuclear translocation and GR-glucocorticoid response element (GRE) binding (Ito and Mercado, 2009) . Consistent with previous findings (Itoh et al., 2002; Rogatsky et al., 1998) , we found that GR-Ser 226 phosphorylation via JNK1 activation might inhibit GR nuclear translocation leading to impairment of corticosteroid sensitivity (Kobayashi et al., 2011) . Budziszewska et al. showed that the serine/threonine phosphatase PP2A amplifies GR action through dephosphorylation of JNK (Budziszewska et al., 2010) . In support of this,
we also found that PP2A regulates GR nuclear translocation concomitant with dephosphorylation of GR-Ser 226 via JNK1 (Kobayashi et al., 2011) . Besides PP2A, it has been reported that activation of JNKs is regulated by dual-specificity protein phosphatases (DUSPs), which belong to the superfamily of protein tyrosine phosphatases and recognize phospho-serine/threonine and phospho-tyrosine residues within one substrate (Alonso et al., 2004; Tonks, 2006) . Based on sequence similarity, DUSPs are further classified into six subgroups, which include mitogen-activated protein kinase phosphatases (MKPs), slingshot protein phosphatases, phosphatases of regenerating liver (PRLs), Cdc14 phosphatases, phosphatase and tensin homolog deleted on chromosome 10 (PTENs), myotubularins, and atypical DUSPs (Patterson et al., 2009 ).
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-8 -MKPs contain a highly conserved C-terminal catalytic domain and an N-terminal CH2 domain (for Cdc25 homology 2) including critical KIMs (kinase-interacting motifs) which confer specific mitogen-activated protein kinase (MAPK) substrate specificity. The activation of MAPKs requires phosphorylation of both the threonine (Thr) and tyrosine (Tyr) residues located within the TXY (Thr-Xaa-Tyr) motif by dual specificity MAPK kinases (Davis, 2000) , whereas
MKPs dephosphorylate MAPKs at both phospho-Thr and phospho-Tyr residues within the MAPK TXY activation motif (Patterson et al., 2009 ).
Here we have investigated the role of MKPs in corticosteroid sensitivity, especially via regulation of JNK1-GR-Ser 226 pathway. Amongst MKPs, we focused on DUSP1, DUSP4, DUSP8 and DUSP16, which are predominantly involved in dephosphorylation of JNK (Chen et al., 2001; Chu et al., 1996; Liu et al., 1995; Tanoue et al., 2001 ). In addition, as another target that can dephosphorylate JNK, we also explored DUSP22, an atypical DUSP, which share some characteristics of the MKPs with the consensus DUSP catalytic domain but lack of the N-terminal CH2 domain (Aoyama et al., 2001) .
In this study performed in the U937 monocytic cell line and in PBMCs from healthy and severe asthmatic subjects, we found that DUSP4, one of the MKPs, regulates corticosteroid MOL #107656
-9 -sensitivity by inhibition of JNK1 and GR-Ser 226 phosphorylation.
-13 -JNK1, and the rabbit polyclonal GR Ab.
Quantitative RT-PCR
Total RNA extraction and reverse transcription were performed using a NucleoSpin RNA 
Glucocorticoid receptor nuclear translocation
Cells were treated with Dex (10 -7 M) for 1 h. Nuclear and cytoplasmic GR were measured by Western blot. TBP (for nuclear protein) or  tubulin (for cytoplasmic protein) expression was used as a control for protein loading. As an index of GR nuclear translocation, the ratio of nuclear GR to TBP was calculated.
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Protein phosphatase activity
Phosphatase activity was assayed by using the 
RNA interference
DUSP1, DUSP4, DUSP8, DUSP16 and DUSP22 siRNAs and non-silencing scrambled control siRNA (AllStars Negative Control siRNA) were purchased from QIAGEN (Crawley, UK). For U937 cells, the siRNA sequences (0.5 M) were transfected using an HVJ Envelope (HVJ-E)
Vector Kit GenomONE-Neo (Ishikawa Sangyo Kaisha Ltd., Osaka, Japan) as described
Imaging Flow Cytometer
Purified PBMCs were fixed and permeabilized by BD Cytofix/Cytoperm solution (BD Biosciences), followed by incubation with DUSP4, phospho-JNK or phospho-GR-Ser 226 antibodies. DUSP4, phospho-JNK or phospho-GR-Ser 226 were further labeled with APC-, AF488-or PE-conjugated secondary antibodies, respectively. The expression levels of these molecules were measured using Amnis  ImageStream  X Mark II and mean fluorescence intensities (MFI) were analyzed using IDEAS version 6.0 (Merck Millipore, Darmstadt, Germany) as previously described (Marangon et al., 2013) .
Statistical analysis
Comparisons of two groups of data were performed using Mann-Whitney U test or paired t-test as appropriate. Correlation coefficients were calculated with the use of Pearson's rank method.
Other data were analyzed by ANOVA with post hoc test adjusted for multiple comparisons This article has not been copyedited and formatted. The final version may differ from this version. Western blotting analysis confirmed more than 30% knockdown (KD) of DUSPs, at least to the same extent (Supplemental Figure 1 ). DUSP1 and DUSP4 KDs reduced the inhibitory effect of Dex on TNF-induced IL-8 production, so that Dex-IC50 increased significantly from 108.2 (± 10.5) for scrambled control to 185.8 (± 2.8) for DUSP1 and to 271.0 (± 9.1) for DUSP4.
Notably, DUSP4 siRNA increased the Dex-IC50 values on IL-8 production to significantly greater extent than DUSP1 siRNA (Fig. 1A) . In addition, DUSP4 KD significantly reduced the ability of Dex to enhance FKBP51 and inhibit TNF-induced IFN and IL-8 mRNA expressions (Fig. 1B) .
We next examined whether DUSP4 is associated with JNK1 and GR phosphorylation which might be a key factor in the regulation of GR nuclear translocation (Kobayashi et al., 2011) . Although both DUSP1 and DUSP4 KDs enhanced JNK1 phosphorylation (Fig. 1C) , only DUSP4 KD increased the phosphorylation levels of GR-Ser 226 (Fig. 1D ).
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 1E ), suggesting that DUSP4 may control both JNK1
and GR phosphorylation levels. Importantly, as GR is mainly located in the cell cytoplasm but not in the cell nucleus under normal condition, it can be speculated that DUSP4 associates with JNK1 and GR in the cell cytoplasm. In line with these findings, DUSP4 knockdown reduced GR translocation from cell cytoplasm into nucleus (Fig. 1F ).
DUSP4 is reduced in PBMCs from severe asthma
We confirmed that in PBMCs from severe asthmatics, DUSP4 protein expression was significantly reduced compared with those from healthy volunteers (DUSP4: 0.33 ± 0.02 in healthy volunteers, 0.22 ± 0.02 in severe asthmatics) ( Fig. 2A) .
Analysis using Imaging Flow Cytometer visually showed reduced DUSP4 expression level which was negatively correlated with phosphorylation levels of GR-Ser 226 and JNK ( Fig.   2B and C). These findings suggest that impaired DUSP4 might fail to dephosphorylate JNK and GR-Ser 226 resulting in corticosteroid insensitivity observed in severe asthma.
DUSP4 is a therapeutic target for restoration of corticosteroid sensitivity
In order to confirm that DUSP4 may be a therapeutic target, we next examined the effect of DUSP4 activation on restoration of corticosteroid sensitivity. Formoterol, a long-acting 2-adrenergic agonist (LABA), increased activity of immunoprecipitated (IP)-DUSP4 in whole cell extracts of U937 cells in a dose dependent manner with maximum effect at 10 -9 M (1.6 fold for 10 -9 M vs. non-treatment) (Fig. 3A) . Salmeterol (10 -7 M), another LABA, also activated IP-DUSP4 but to a lesser extent than formoterol while albuterol (10 -7 M), a short-acting 2-adrenergic agonist, had no effect. In addition, the LABA-dependent increase in IP-DUSP4 activity was antagonized by ICI-118551, a selective 2-adrenergic receptor antagonist (Fig. 3B ), suggesting that DUSP4 is activated by LABAs through 2-adrenergic receptors.
As observed in U937 cells ( Fig. 1 A and B) , in PBMCs from healthy volunteers, DUSP4 KD significantly reduced the ability of Dex to enhance FKBP51 and inhibit TNF-induced IFN and IL-8 mRNA expressions (Fig. 3C ). DUSP4 KD also significantly reduced IP-DUSP4 activity (Fig. 3D) . Formoterol significantly restored IP-DUSP4 activity in DUSP4 KD PBMCs (Fig. 3D ) and concomitantly restored corticosteroid sensitivity improving This article has not been copyedited and formatted. The final version may differ from this version. 
MOL #107656
-21 -the efficacy of Dex up to 80% (Fig. 3C ). In addition, we confirmed that formoterol-mediated 
Discussion
In this study, we examined the involvement of DUSPs on regulation of corticosteroid sensitivity in U937 monocytic cell line and PBMCs from healthy subjects and severe asthmatic patients.
We revealed that DUSP4 is associated with JNK1 and GR in the cytoplasmic complex and that knockdown of DUSP4 reduces GR nuclear translocation most likely via hyperphosphorylation of JNK1 and GR-Ser 226 . This contributes to corticosteroid insensitivity, measured as increased IC50 value for the inhibitory effect of Dex on TNF-induced IL-8 secretion. We demonstrated that DUSP4 is reduced in PBMCs from severe asthmatics and that DUSP4 expression negatively correlates with enhanced phosphorylation levels of JNK1 and GR-Ser 226 in these cells. Furthermore, we showed that DUSP4 was activated by formoterol, and that formoterol restored corticosteroid sensitivity in PBMCs in which DUSP4 activity was reduced. Thus, DUSP4 appears to regulate corticosteroid sensitivity via dephosphorylation of JNK1 and GR-Ser 226 .
DUSP4 is a member of MKP family of phosphatases known to dephosphorylate mainly ERK1/2 and JNK (Camps et al., 2000) . DUSP4 has been shown to play roles in cellular functions such as cell apoptosis and senescence Tresini et al., 2007) . Consistent with the previous report in severe asthma (Bhavsar et al., 2008) , we have also found that reduced expression of DUSP1 caused corticosteroid insensitivity, but to a significantly lesser extent than reduced expression of DUSP4. DUSP4 (but also DUSP1, 8, 10 and 16) deletion by siRNA enhances JNK phosophorylation under oxidative stress and suggests that these DUSPs coordinate to control JNK activation (Teng et al., 2007) . Similarly, it seems that DUSP1, 4, 8, 16 and 22 are involved in regulation of JNK phosphorylation in our study (data shown only for DUSP1 and DUSP4) but only reduced expression of DUSP1 and DUSP4 enhanced corticosteroid sensitivity. However, in contrast to DUSP4, reduced expression of DUSP1 had no effect on the phosphorylation of GR-Ser 
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-24 -dephosphorylate MAPKs in both cytoplasm and cell nucleus to , our co-immunoprecipitation study showed that DUSP4 associates with JNK1 and GR mainly located in the cytoplasm but not in the nucleus under baseline conditions. Thus, DUSP4 can dephosphorylate JNK1 and GR-Ser 226 in the cytoplasm, resulting in increased GR nuclear translocation.
We have previously shown that protein phosphatase 2A (PP2A), a serine/threonine phosphatase, is activated by formoterol and that activated PP2A could restore corticosteroid sensitivity through dephosphorylation of JNK1 and GR-Ser 226 (Kobayashi et al., 2011) . In addition, formoterol has been shown to restore corticosteroid sensitivity by dephosphorylation of GR in PBMC from severe asthma and in IL-2/IL-4-induced corticosteroid insensitive PBMCs (Mercado et al., 2011) . This is the reason why we investigated formoterol as a possible activator of DUSP4. In fact, our present findings indicate that formoterol activates DUSP4 and suggest that DUSP4 activation may be a therapeutic target for restoration of corticosteroid sensitivity. It remains unclear how formoterol activates DUSP4. Nevertheless, this study shows that DUSP4 may be activated via 2-adrenergic receptor pathway while PP2A has been reported to be activated by formoterol in 2-adrenergic receptor-independent pathway (Kobayashi et al., 2012) . GR-Ser 226 phosphorylation, which links to inactivation of GR via JNK signaling, has been reported to be regulated also by protein phosphatase 5 (PP5), another serine/threonine phosphatase. PP5 is associated with GR-heat shock protein 90 complex and dephosphorylates GR-Ser 226 (Wang et al., 2007) . PP5 also has the potential to control GR ability to translocate into This article has not been copyedited and formatted. The final version may differ from this version. 
-26 -the nucleus and to bind glucocorticosteroids (Hinds and Sanchez, 2008) . However, in our study PP5 reduction by siRNA did not induce corticosteroid insensitivity (data not shown). Protein tyrosine phosphatase PTP-RR, which can regulate PP2A activity, is also involved in regulation of corticosteroid sensitivity (Kobayashi et al., 2016) . Thus, several phosphatases might regulate corticosteroid sensitivity in collaboration. As shown in Supplemental Figure 1 , knockdown of DUSP4 using siRNA in our system was limited (~30% reduction). Taken together, in this study DUSP4 knockdown reduced corticosteroid sensitivity to a small but significant extent.
In conclusion, we examined the role of DUSPs in the regulation of corticosteroid sensitivity. We showed that DUSP4 is associated with GR and JNK1 in the cell cytoplasm and regulates GR nuclear translocation, most likely via dephosphorylation of JNK1 and GR-Ser 226 .
Reduced DUSP4 expression is associated with hyperphosphorylation of GR-Ser 226 in PBMCs from severe asthmatics and may contribute to corticosteroid insensitivity in severe asthma.
Indeed, DUSP4 activation by formoterol restores impaired corticosteroid sensitivity, indicating that DUSP4 is crucial in regulation of corticosteroid sensitivity and therefore might be a novel therapeutic target in patients with severe asthma.
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